New Issue: Credit Suisse sells $851,000 10.45% reverse convertibles linked to Boston Scientific

By E. Janene Geiss

Philadelphia, April 26 - Credit Suisse, Nassau branch, priced $851,000 of 10.45% reverse convertible securities due Oct. 30, 2007 linked to Boston Scientific Corp. stock, according to a 424B2 filing with the Securities and Exchange Commission.

Payout at maturity will be par unless Boston Scientific stock falls below the knock-in price of $12.67 - 80% of the initial value - during the life of the notes and finishes below its initial price of $15.84, in which case the payout will be a number of Boston Scientific shares equal to $1,000 divided by the initial share price.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:	Credit Suisse, Nassau branch
Issue:	Reverse convertible securities
Underlying stock:	Boston Scientific Corp.
Amount:	$851,000
Maturity:	Oct. 30, 2007
Coupon:	10.45%, payable quarterly
Price:	Par
Payout at maturity:	Par unless Boston Scientific stock falls below the knock-in price of $12.67 during the life the notes and finishes below its initial value, in which case payout will be a number of Boston Scientific shares equal to $1,000 divided by the initial share price
Initial price:	$15.84
Knock-in price:	$12.67, 80% of $15.84
Exchange ratio:	63.131
Pricing date:	April 24
Settlement date:	April 30
Agent:	Credit Suisse Securities (USA) LLC
Agent fee:	2%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.